105
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Formulation, optimization and full characterization of mirtazapine loaded aquasomes: a new technique to boost antidepressant effects

, &
Pages 206-222 | Received 30 Jun 2023, Accepted 29 Jan 2024, Published online: 28 Feb 2024

References

  • Musallam AA, Mahdy MA, Elnahas HM, et al. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design: in-vitro characterization and in-vivo assessment. Drug Deliv. 2022;29(1):1582–1594. doi: 10.1080/10717544.2022.2075985.
  • Hamed HE, Hussein AA. Preparation, in vitro and ex-vivo evaluation of mirtazapine nanosuspension and nanoparticles incorporated in orodispersible tablets. Iraqi J Pharm Sci. 2020;29(1):62–75.
  • Ezealisiji KM, Mbah CJ, Osadebe P, et al. Pharmacokinetics studies of mirtazapine loaded nanoemulsion and its evaluation as transdermal delivery system. Chem Pharm Res. 2017;9(3):74–84.
  • Hashem FM, Abd Allah FI, Abdel-Rashid RS, et al. Glibenclamide nanosuspension inhaler: development, in vitro and in vivo assessment. Drug Dev Ind Pharm. 2020;46(5):762–774. doi: 10.1080/03639045.2020.1753062.
  • Patel S, Aundhia C, Seth A, et al. Aquasomes: a novel approach in drug carrier system. ejpmr. 2016;3(9):198–201.
  • Rojas-Oviedo I, Salazar-López RA, Reyes-Gasga J, et al. Elaboration and structural analysis of aquasomes loaded with indomethacin. Eur J Pharm Sci. 2007;32(3):223–230. doi: 10.1016/j.ejps.2007.07.008.
  • Ayom GE, Malima NM, Owonubi SJ, et al. Aquasomes: a novel nanocarrier system for drug delivery, in advanced nanoformulations. Academic Press, Elsevier; 2023. p. 281–301.
  • Kulkarni S, Prabhakar B, Shende P. Aquasomes: advanced vesicular-based nanocarrier systems. Curr Pharm Des. 2022;28(29):2404–2414. doi: 10.2174/1381612828666220728112741.
  • Duangjit S, Kraisit P. Optimization of orodispersible and conventional tablets using simplex lattice design: relationship among excipients and banana extract. Carbohydr Polym. 2018;193:89–98. doi: 10.1016/j.carbpol.2018.03.087.
  • Mehta DM, Dave DJ, Dadhaniya DV, et al. Application of Box-Behnken design to formulate and optimize multipolymeric fast dissolving film of rizatriptan benzoate. Asian J Pharm. 2014;8(1):38–45.
  • Ferreira SLC, Bruns RE, Ferreira HS, et al. Box-Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta. 2007;597(2):179–186. doi: 10.1016/j.aca.2007.07.011.
  • Beg S, Akhter S. Box–Behnken designs and their applications in pharmaceutical product development. In: Design of experiments for pharmaceutical product development. Singapore: Springer. Vol. 1. 2021. p. 77–85. doi: 10.1007/978-981-33-4717-5_7.
  • Kaur K, Kush P, Pandey RS, et al. Stealth lipid coated aquasomes bearing recombinant human interferon-α-2b offered prolonged release and enhanced cytotoxicity in ovarian cancer cells. Biomed Pharmacother. 2015;69:267–276. doi: 10.1016/j.biopha.2014.12.007.
  • Banerjee S, K KS. Preparation and evaluation of surface modified nanoparticles of calcium phosphate as extract carrier. Int J App Pharm. 2020;12(4):248–257. doi: 10.22159/ijap.2020v12i4.38126.
  • Asfour MH. Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques. Drug Deliv Transl Res. 2021;11(1):1–23. doi: 10.1007/s13346-020-00746-z.
  • Vengala P, Dintakurthi S, Subrahmanyam CVS. Lactose coated ceramic nanoparticles for oral drug delivery. J Pharm Res. 2013;7(6):540–545. doi: 10.1016/j.jopr.2013.06.015.
  • Banerjee S, McCracken S, Hossain MF, et al. Electrochemical detection of neurotransmitters. Biosensors. 2020;10(8):101. doi: 10.3390/bios10080101.
  • Vengala P, Subrahmanyam CVS, Gangaraju M. In vitro and in vivo evaluation of piroxicam loaded ceramic nanoparticles. Int J Pharmaceut Sci Res. 2016;7:303–309.
  • Kallingal A, Suresh AM. Aquasomes nanocarriers for delivery of small molecules. Int J Med Phar Sci. 2021;11(07):1.
  • Narang N. Aquasomes: self-assembled systems for the delivery of bioactive molecules. Asian J Pharm. 2012;6(2):95. doi: 10.4103/0973-8398.102931.
  • Kommineni S, Ahmad S, Vengala P, et al. Sugar coated ceramic nanocarriers for the oral delivery of hydrophobic drugs: formulation, optimization and evaluation. Drug Dev Ind Pharm. 2012;38(5):577–586. doi: 10.3109/03639045.2011.617884.
  • Kutlehria A, Kaushik P, Sharma S, et al. Aquasomes as a carrier system for oral delivery of bromelain. Int Res J Pharm. 2018;9(8):123–129.
  • Antil R, Kadawla M, Rao L. Recent advances in aquasomes carrier nanotechnology for drug delivery. Int J Nanobiotechnol. 2021;7(1):35–44.
  • Jagdale S, Karekar S. Bird’s eye view on aquasome: formulation and application. J Drug Delivery Sci Technol. 2020;58:101776. doi: 10.1016/j.jddst.2020.101776.
  • Ezealisiji KE, Mbah CJ, Osadebe PO. Aqueous solubility enhancement of mirtazapine: effect of cosolvent and surfactant. Pharm Pharmacol. 2015;6(10):471–476.
  • Amin BH, Ahmed HY, El Gazzar EM, et al. Enhancement the mycosynthesis of selenium nanoparticles by using gamma radiation. Dose Response. 2021;19(4):15593258211059323. doi: 10.1177/15593258211059323.
  • Goyal AK, Khatri K, Mishra N, et al. Aquasomes–a nanoparticulate approach for the delivery of antigen. Drug Dev Ind Pharm. 2008;34(12):1297–1305. doi: 10.1080/03639040802071661.
  • Damera DP, Kaja S, Janardhanam LSL, et al. Synthesis, detailed characterization, and dual drug delivery application of BSA loaded aquasomes. ACS Appl Bio Mater. 2019;2(10):4471–4484. doi: 10.1021/acsabm.9b00635.
  • Umashankar MS, Sachdeva RK, Gulati M. Aquasomes: a promising carrier for peptides and protein delivery. Nanomedicine. 2010;6(3):419–426. doi: 10.1016/j.nano.2009.11.002.
  • Gayakwad MD, Kumar MA. Dr. Abhilasha Mittal. Research and Development in Pharmaceutical Science Volume III. India: Bhumi Publishing. 2022; p 10–18.
  • Naureen F, Shah Y, Shah SI, et al. Formulation development of mirtazapine liquisolid compacts: optimization using central composite design. Molecules. 2022;27(13):4005. doi: 10.3390/molecules27134005.
  • El-Say KM, Hosny KM. Optimization of carvedilol solid lipid nanoparticles: an approach to control the release and enhance the oral bioavailability on rabbits. PLoS One. 2018;13(8):e0203405. doi: 10.1371/journal.pone.0203405.
  • Jain SS, Jagtap PS, Dand NM, et al. Aquasomes: a novel drug carrier. J Appl Pharm Sci.  2012;2(1):184–192.
  • Refai H, Osman DA, Khalifa MK, et al. Trifluoperazine-loaded leciplexes as potential nasal delivery systems for treatment of depression %. J Azhar Int J Pharm Med Sci. 2022;2(2):70–82.
  • Omar MM, Eleraky NE, El Sisi AM, et al. Development and evaluation of in-situ nasal gel formulations of nanosized transferosomal sumatriptan: design, optimization, in vitro and in vivo evaluation. Drug Des Devel Ther. 2019;13:4413–4430. doi: 10.2147/DDDT.S235004.
  • Barbosa Méndez S, Salazar-Juárez A. Mirtazapine attenuates anxiety-and depression-like behaviors in rats during cocaine withdrawal. J Psychopharmacol. 2019;33(5):589–605. doi: 10.1177/0269881119840521.
  • Rogóż Z, Kabziński M. Enhancement of the anti-immobility action of antidepressants by risperidone in the forced swimming test in mice. Pharmacol Rep. 2011;63(6):1533–1538. doi: 10.1016/s1734-1140(11)70717-4.
  • Zanier-Gomes PH, de Abreu Silva TE, Zanetti GC, et al. Depressive behavior induced by social isolation of predisposed female rats. Physiol Behav. 2015;151:292–297. doi: 10.1016/j.physbeh.2015.07.026.
  • Kraeuter AK, Guest PC, Sarnyai Z. The forced swim test for depression-like behavior in rodents. Pre-Clinical Models. Methods in Molecular Biology, New York: Humana Press, 2019; vol 1916, p 75–80.
  • Zimcikova E, Simko J, Karesova I, et al. Behavioral effects of antiepileptic drugs in rats: are the effects on mood and behavior detectable in open-field test? Seizure. 2017;52:35–40. doi: 10.1016/j.seizure.2017.09.015.
  • Yasir M, Chauhan I, Zafar A, et al. Buspirone loaded solid lipid nanoparticles for amplification of nose to brain efficacy: formulation development, optimization by Box-Behnken design, in-vitro characterization and in-vivo biological evaluation. J Drug Delivery Sci Technol. 2021;61:102164. doi: 10.1016/j.jddst.2020.102164.
  • Roy H. Box-Behnken design for optimization of formulation variables for fast dissolving tablet of urapidil. Asian J Pharm. 2018;12(03): s946–954.
  • Sofronia AM, Baies R, Anghel EM, et al. Thermal and structural characterization of synthetic and natural nanocrystalline hydroxyapatite. Mater Sci Eng C Mater Biol Appl. 2014;43:153–163. doi: 10.1016/j.msec.2014.07.023.
  • Martínez-Castañón G, Loyola-Rodríguez J, Zavala-Alonso N, et al. Preparation and characterization of nanostructured powders of hydroxyapatite. Superficies y vacío. 2012;25(2):101–105.
  • Gombas A, Szabó-Révész P, Kata M, et al. Quantitative determination of crystallinity of α-lactose monohydrate by DSC. J Therm Anal Calorim. 2002;68(2):503–510.
  • Cherian AK, Rana AC, Jain SK. Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm. 2000;26(4):459–463. doi: 10.1081/ddc-100101255.
  • Santhosh S, Pandey NK, Singh SK, et al. An overview of preparation, characterization, and application of aquasomes. The Era of Nanotechnology: Emergence Essentials. 2021:97.
  • El-Say KM, Abd-Allah FI, Lila AE, et al. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. J Liposome Res. 2016;26(1):57–68. doi: 10.3109/08982104.2015.1029495.
  • Yadav YC, Pattnaik S, Swain K, et al. Curcumin loaded mesoporous silica nanoparticles: assessment of bioavailability and cardioprotective effect. Drug Dev Ind Pharm. 2019;45(12):1889–1895. doi: 10.1080/03639045.2019.1672717.
  • Kaur M, Bhatia RK, Pissurlenkar RRS, et al. Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells. Carbohydr Polym. 2014;101:614–622. doi: 10.1016/j.carbpol.2013.09.077.
  • Naresh WR, Dilip DV, Sunil KP. Xyloglucan based nasal in situ gel formulation of mirtazapine for treatment of depression. Indian J. Pharm. Educ. Res. 2020;54:s210–s219.
  • Thakkar HP, Patel AA, Chauhan NP. Intranasal mucoadhesive microemulsion of mirtazapine: pharmacokinetic and pharmacodynamic studies. Asian J Pharm. 2013;7(1):36. doi: 10.4103/0973-8398.110934.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.